Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
The Christie Hospital · Tata Memorial Hospital · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,088
total citations
- FWCI
- 120.66
- Percentile
- 100%
- References
- 37
Citations per year
Authors
11Topics & keywords
Topics
Keywords
- Gefitinib
- Medicine
- Internal medicine
- Placebo
- Hazard ratio
- Clinical endpoint
- Lung cancer
- Population
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.